Structured Oncology Prescreening. Transparent Trial Feasibility.
Kenvar Lucent is a workflow platform designed for oncology research teams to evaluate eligibility, document prescreening decisions, and monitor trial feasibility with audit-ready transparency.
Currently onboarding initial design partners.
Prescreening and feasibility workflows are fragmented.
Manual Tracking
Spreadsheets, email threads, disconnected notes.
Limited Visibility
Eligibility decisions lack structured traceability.
Feasibility Blind Spots
Enrollment risk often becomes visible too late.
Kenvar provides structured, auditable workflow support.
A purpose-built platform for oncology prescreening and trial feasibility.
Structured Eligibility Evaluation
Evaluate inclusion and exclusion criteria in a consistent, reviewable format.
Decision Traceability
Every status change and evaluation is recorded and timestamped.
Feasibility Insight
Monitor prescreening trends and enrollment signals across trials.
Role-Based Access
Clear visibility for CRCs, PIs, and administrators.
Built for clinical research workflows.
Purpose-built interfaces designed for the way oncology research teams actually work.
app.kenvar.com/dashboard
Dashboard
Operational visibility across active oncology trials.
app.kenvar.com/prescreening
Prescreening Worklist
Structured candidate evaluation with transparent status tracking.
app.kenvar.com/prescreening/AML302-SCR-021
Eligibility Detail View
Criterion-level evaluation with immutable activity logs.
Designed for Oncology Research Teams
Clinical Research Coordinators
Structured prescreening workflow and eligibility tracking.
Principal Investigators
Transparent oversight and enrollment visibility.
Research Administrators
Trial-level feasibility insight and operational reporting.
Currently in Design Partner Phase
Kenvar is currently onboarding a limited number of oncology research sites to participate in early workflow validation and design collaboration.
We are seeking structured feedback from CRCs and PIs to refine prescreening and feasibility workflows before broader release.
Founded by a former intelligence analyst and experienced software architect with over 20 years building secure systems in regulated environments.
Interested in shaping the future of oncology prescreening?
No sales. No obligation. Just workflow discussion.